HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Tango Therapeutics R&D President Sells $617k in Shares

Created at 3 Jun · 11:05 PM1 source
IN SHORT

Crystal Adam, Tango Therapeutics' R&D president, sold shares worth $617,000. The transaction involved the company's stock.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

$617,000value of shares sold

Who's Involved

Crystal Adam
R&D president at Tango Therapeutics
Tango Therapeutics
Company whose shares were sold

↳ Why This Matters

Insider selling can sometimes signal a lack of confidence from company executives, potentially impacting investor sentiment.

Key facts

  • Crystal Adam, R&D president at Tango Therapeutics, sold shares.
  • The value of the shares sold was $617,000.

Crystal Adam, the President of Research and Development at Tango Therapeutics, has sold shares of the company. The transaction amounted to $617,000. The sale involved shares of Tango Therapeutics.

Frequently asked questions

Crystal Adam, the R&D president of Tango Therapeutics, sold shares.

The shares sold were valued at $617,000.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

3 Jun · 10:41 PM
Tango Therapeutics R&D president Crystal Adam sold shares valued at $617,000.
Investing.com via PiQSuite

Sources

T1
Tango Therapeutics R&D president Crystal Adam sells $617k in sharesm.piqsuite.com

Related Stories

JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM
Memory Stocks Plunge as Year's Hottest Trade Unravels
8 Jul · 2:35 PM
SpaceX Analyst Maintains Neutral Stance Amid Wall Street Buy Frenzy
8 Jul · 10:00 AM
SK Hynix $28B ADR bookbuild closes Wednesday amid strong demand
8 Jul · 7:57 AM
AI and SpaceX Wealth Fuels New Luxury Spending Habits
8 Jul · 10:06 AM